Dr Reddy’s Laboratories

Dr Reddy’s relaunch OTC Famotidine Tablets USP, 10 mg and 20 mg, in US

Read more

Experts laud DCGI ruling to conduct phase II/III clinical trials of Sputnik-V in India

Read more

DRL joins SBTi and sets 2030 GHG emission targets

Read more

Dr Reddy’s launches generic sapropterin dihydrochloride tablets for oral use in US

Read more

Dr Reddy’s seeks DCGI approval for Phase 3 clinical trials of Sputnik V in India

Read more

Dr Reddy’s launches Cinacalcet Tablets in US

Read more

Dr Reddy’s launches dimethyl fumarate DR capsules in US

Read more

Dr Reddy’s launches dexmedetomidine hydrochloride in 0.9% sodium chloride injection in US

Read more

Dr Reddy’s announces settlement of Revlimid capsules patent litigation with Celgene in US

Read more

Dr Reddy’s launches OTC Olopatadine Hydrochloride Ophthalmic Solution in US

Read more